Correction: Martins et al. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210

Martins, Ana M.; Gomes, Ana L.; Boas, Inês Vilas; Marto, Joana; Ribeiro, Helena M.

doi:10.3390/ph15070849

Open AccessCorrection

Correction: Martins et al. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210

¹

Research Institute for Medicines (iMed.ULisboa), Universidade de Lisboa, 1649-003 Lisbon, Portugal

²

Faculdade de Farmácia, Universidade de Lisboa, 1649-003 Lisbon, Portugal

^*

Authors to whom correspondence should be addressed.

Pharmaceuticals 2022, 15(7), 849; https://doi.org/10.3390/ph15070849

Submission received: 23 May 2022 / Accepted: 6 June 2022 / Published: 11 July 2022

(This article belongs to the Special Issue New Horizons in Dermal and Transdermal Drug Delivery Systems)

Download Versions Notes

The authors would like to make the following corrections about the published paper [1]. The changes are as follows:

Missing Citation

In the original publication, refs. [2,3] was not cited. The citation has now been inserted in 4. The Skin Endocannabinoid System and the Use of Cannabinoids as a Potential Treatment for Skin Inflammatory Diseases, 4.1. The Skin Endocannabinoid System, Table 2 caption. Newly add references as [47,48] in the original paper, the order of some reference citation has been adjusted correspondingly.

“Table 2. The different classes of cannabinoids located in the skin, and some examples [15,37,47,48].”

The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

References

Martins, A.M.; Gomes, A.L.; Vilas Boas, I.; Marto, J.; Ribeiro, H.M. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210. [Google Scholar] [CrossRef]
Muller, C.; Morales, P.; Reggio, P.H. Cannabinoid Ligands Targeting TRP Channels. Front. Mol. Neurosci. 2019, 11, 487. [Google Scholar] [CrossRef]
Mnekin, L.; Ripoll, L. Topical Use of Cannabis sativa L. Biochemicals. Cosmetics 2021, 8, 85. [Google Scholar]

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Share and Cite

MDPI and ACS Style

Martins, A.M.; Gomes, A.L.; Boas, I.V.; Marto, J.; Ribeiro, H.M. Correction: Martins et al. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210. Pharmaceuticals 2022, 15, 849. https://doi.org/10.3390/ph15070849

AMA Style

Martins AM, Gomes AL, Boas IV, Marto J, Ribeiro HM. Correction: Martins et al. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210. Pharmaceuticals. 2022; 15(7):849. https://doi.org/10.3390/ph15070849

Chicago/Turabian Style

Martins, Ana M., Ana L. Gomes, Inês Vilas Boas, Joana Marto, and Helena M. Ribeiro. 2022. "Correction: Martins et al. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210" Pharmaceuticals 15, no. 7: 849. https://doi.org/10.3390/ph15070849

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Correction: Martins et al. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210

References

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI